Tech & Science
The US FDA approved a new drug designed to slow cognitive decline in patients in the early stages of Alzheimer's disease.
Hi, what are you looking for?
The US FDA approved a new drug designed to slow cognitive decline in patients in the early stages of Alzheimer's disease.
The US FDA's approval process for a controversial drug used to treat Alzheimer's was "rife with irregularities."
The Food and Drug Administration unveiled a new proposal last week that would change the criteria for a food to be labeled as "health."
Of greatest concern were products with high levels of bacteria that can cause serious infections and with products contaminated with benzene.
Features introduced to exploit the advantages of digital data capture also increase potential cybersecurity risks.
The U.S. health regulator on Monday revised the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli Lilly to limit their use, as the...
Proctor & Gamble is recalling nearly three dozen dry shampoos, dry conditioners, and other hair care products, after “unexpected levels” of benzene, a cancer-causing...
Food safety is paramount, and consumers should understand the practices and protocols of the product.
How can public faith in medical devices with an artificial intelligence aspect be boosted? New guidance is a start.
The U.S. Food and Drug Administration (FDA) on Monday warned of an increased risk of Guillain-Barre (GBS), a rare neurological disorder.